Major Advantage of Surgical Sealants and Adhesives Device Is To Manage Blood Loss In Patients

Major Factor Which Are Driving The Growth Of Surgical Sealants and Adhesives Market :

Increasing incidence of chronic diseases along with the rapid growth in the geriatric population, increasing need manage blood loss in patients, and growing number of surgical procedures performed are the major factors driving the growth of the surgical sealants and adhesives market

Get PDF Brochure Here : http://bit.ly/2hMM8eA

On the basis of product, the market is segmented into natural/biological sealants and adhesives and synthetic & semi-synthetic sealants and adhesives. The natural/biological sealants and adhesives segment is further categorized into type and origin.

On the basis of type, the natural/biological sealants segment have been divided into polypeptide/protein-based and polysaccharide-based sealants and adhesives. The polypeptide/protein-based sealants segment is further categorized into fibrin, gelatin, collagen, and albumin-based adhesives, while the polysaccharide-based sealants segment comprise of chitosan-based and other polysaccharide-based adhesives.

 On the basis of origin, the natural/biological sealants and adhesives segment is categorized into human blood-based and animal-based. The synthetic and semi-synthetic sealants and adhesives segment is divided into cyanoacrylates, polyethylene glycol hydrogels, urethane-based adhesives, and other synthetic adhesives.

On the basis of application, the global surgical sealants and adhesives market is segmented into CNS, general, cardiovascular, orthopedic, cosmetic, urological, pulmonary, ophthalmic surgeries, and other applications.

To Know More : http://bit.ly/2fuaGZi

Future of Parkinson's Disease Treatment Market

Parkinson’s disease therapeutic drugs act upon the central nervous system to control or reduce the symptoms of Parkinson’s disease. The global Parkinson’s disease treatment market is expected to reach USD 5.69 billion by 2022 from USD 4.24 billion in 2017, at a CAGR of 6.1%.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=47265247

Globally, the Parkinson’s disease treatment market is witnessing a moderate growth due to factors such as increasing prevalence of Parkinson’s disease; rising geriatric population; and support for research on Parkinson’s disease. 

Over the last few decades, key players operating in this market are focusing on offering new and innovative products. Based on drug class, the Parkinson’s disease therapeutic drugs market is segmented into carbidopa/levodopa dopamine receptor agonists, MAO-inhibitors, COMT-inhibitors, anticholinergics and other drugs. The carbidopa/levodopa segment is expected to register the highest CAGR during the forecast period. This is due to carbidopa/levodopa drugs are more potent and widely used in the treatment of Parkinson’s disease in comparison to other therapeutic drugs.

By distribution channel, the market is segmented into hospital pharmacies, retailer pharmacies, and online pharmacies. The online pharmacies segment is expected to register the highest growth rate during the forecast period. Advancements such as 24/7 availability, home delivery, and discount on medicines are driving factors for online pharmacies segment.

Talk To Our Research Analysts: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=47265247

On the basis of patient care setting, the market is categorized into hospitals and clinics. The hospitals segment is estimated to grow at the fastest rate during the forecast period. The growth of this segment can be attributed to the availability of diagnostics laboratories in the hospital and the presence skilled neurologists.

The Parkinson’s disease treatment market is classified based on regions into North America, Europe, Asia, and the Rest of the World (RoW). Asia is expected to grow at the highest CAGR during the forecast period. Presence key market players and rising aging population are the major factors driving the Parkinson’s disease treatment market in this region. 

Global Thermal Analysis Market Top Industry Key Players Analysis 2017-22

Download PDF Brochure: http://bit.ly/2zsH47D

The global thermal analysis market is expected to grow at a CAGR of 4.6% between 2017 and 2022. Factors such as increasing production of crude and shale oil, patent expiry of blockbuster drugs and biomolecules, and stringent food and product safety regulations are driving the thermal analysis market.

Analysis of the market developments between 2014 and 2017 revealed that several growth strategies such as product launches, enhancements, strategic acquisitions, agreements, contracts, partnerships, collaborations, and expansions were adopted by the market players to strengthen their product portfolios and maintain a competitive position in the thermal analysis market.

As of 2016, Waters (US), NETZSCH (Germany), LINSEIS Germany), Mettler-Toledo (US), PerkinElmer (US), SETARAM (France), and Shimadzu (Japan) held the leading position in the global thermal analysis market. These companies adopted product launches, agreements, partnerships, and collaborations as their key growth strategies in the past three years. Hitachi (Japan), Theta (US), Nanjing Dazhan (China), Instrument Specialists (US), Rigaku (Japan), LECO (US), and Innuo (China) are some of the other major players in this market.

Waters (US) held the leading position in the global thermal analysis market in 2016. The company is one of the top players in the thermal analysis market due to its robust product portfolio that includes all major types of analyzers. NETZSCH (Germany) was among the top players in the global thermal analysis market in 2016.

Download Free Sample Pages of Report: http://bit.ly/2hNCBkK

Spine Biologics Market by Product & End User – 2020

The report "Spine Biologics Market by Product Type (Bone Graft, Bine Graft Substitute, Platelet Rich Plasma, BMAC), Surgery Type (Anterior Cervical Discectomy and Fusion, Posterior Lumbar Interbody Fusion), End User, and Geography - Global Forecast to 2020", The global spine biologics market was valued at $1.90 Billion in 2014 and is expected to reach $2.4 Billion by 2020, at a CAGR of 4.4% during the forecast period of 2015 to 2020.

Browse 55 market data tables and 54 figures spread through 101 pages and in-depth TOC on "Spine Biologics Market”
http://www.marketsandmarkets.com/Market-Reports/spine-biologics-market-67680943.html
Early buyers will receive 10% customization on This report.

Spinal biologics encompass materials that can be utilized in case of bone fusion surgery, spinal cord injury, and degenerative disk disease. Ten years ago, the spine treatment market constituted 75% traditional rods and plates made of metals and 25% biologics. However, since metals are inert materials, they did not stimulate the bone regeneration process. On the other hand, biological materials are proteins that can attract and stimulate cells, promote fusion, and help in the bone healing process

By product type, the spine biologics market is categorized into four types, namely, bone graft substitutes, bone grafts, platelet-rich plasma (PRP), and bone marrow aspirate concentrate therapy. In 2014, the bone graft substitutes segment contributed the largest share of 84.1% to the global market.

Download PDF Brochure : http://bit.ly/2yVrI7Z

By surgery type, the market is segmented into: anterior cervical discectomy and fusion (ACDF), transforaminal lumbar interbody fusion (TLIF), anterior lumbar interbody fusion (ALIF), lateral lumbar interbody fusion (LLIF), and other surgeries. The ACDF segment contributed the largest share to the global spine biologics market in 2014, followed by the transforaminal lumbar interbody fusion (TLIF) segment.

The spine biologics devices are used in spine surgery as lieu allografts as well as a support for bones in and around the spinal region. These devices offer numerous benefits over materials such as pedicle rods and screws that are used in spine fusion. Since metals are inert in nature, they do not stimulate or activate cellular growth or alter cellular functions such as natural healing. Spine biologics, on the other hand, activate cellular growth by stimulating spine fusion.

The driving forces for global spinal biologics market include rising incidence of spinal disorders, rising healthcare expenditure in developing nations owing to growing income levels, rising obesity cases, awareness on the newly developed spine treatment techniques and devices, technological advancements, and rising demand of minimally invasive spine surgeries. The major restraints for this market include lack of expertise, lack of patient awareness, cost of surgery, and unfavourable reimbursement scenario.

The global spine biologics market has been categorized by regions into North America, Europe, Asia-Pacific, and the Rest of the World. North America is the most dominant region in the global market, followed by Europe. Bone graft substitute segment dominated the North American spine biologics market.

Some of the major players in the spine biologics market are Medtronic Inc. (U.S.), DePuy Synthes Companies (U.S.), Zimmer Holding Inc. (U.S.), Nuvasive Inc. (U.S.), Stryker Corporation (U.S.), Orthofix international N.V. (U.S.), K2M Inc. (U.S.), Exactech Inc. (U.S.), Wright Medical Technology Inc. (U.S.), and others.

To Know More : http://bit.ly/2xd8Qz5

Significant Growth in Pharmacovigilance and Drug Safety Software Market

The report “Pharmacovigilance and Drug Safety Software Market by Functionality (Adverse Event Reporting, Fully Integrated Software), Delivery Mode (On-premise, On-demand/Cloud based (SAAS)), End-user (Pharma & Biotech Companies, CROs, BPOs) - Global Forecast to 2019”

The global pharmacovigilance and drug safety software market is poised to grow at a CAGR of 6.5% during 2014-2019, and is expected to reach a value of $154.1 Million in 2019.

Browse 74 market data tables and 57 figures spread through 210 pages and in-depth TOC on
“Pharmacovigilance and Drug Safety Software Market“
http://www.marketsandmarkets.com/Market-Reports/drug-safety-pharmacovigilance-software-market-16831714.html
Early buyers will receive 10% customization on this reports.

In this report has been classified into many segments on the basis of functionality, namely, adverse event reporting software, drug safety audits software, issue tracking software, and fully integrated software. The global pharmacovigilance and drug safety software market is divided into two segments on the basis of delivery mode, namely, on-premise delivery mode and on-demand/cloud based (SaaS) delivery mode.
The global pharmacovigilance and drug safety software market is also segmented on the basis of end users including pharma and biotech companies, contract research organizations (CROs), business process outsourcing (BPO) firms, and other pharmacovigilance service providers.

The Sample Report For This Report@
http://www.marketsandmarkets.com/requestsample.asp?id=16831714

Factors such as rising incidence rates of adverse drug reactions (ADRs) and increasing adoption of pharmacovigilance software by outsourcing companies are driving the growth of the global pharmacovigilance and drug safety software market. In addition; government regulatory bodies (such as the U.S. FDA and EMEA) have intensified safety regulations for prior and post commercialization of drugs, which has increased pressure on the pharmaceutical and biotechnology companies to manufacture safe drugs and evaluate their results post sales.

Thus, growing complexity related to drug safety regulations is expected to drive the growth of the market during the forecast period.

Geography:
North America holds the largest share of the global pharmacovigilance and drug safety software market, followed by Europe. However, Asian and Latin American countries represent high growth markets, owing to a rise in research outsourcing by pharmaceutical giants and growing public and private investments in pharmaceutical R&D in these emerging nations.

Get The PDF Brochure For This Report@
http://www.marketsandmarkets.com/pdfdownload.asp?id=16831714

ArisGlobal (U.S.), Ennov Solutions Inc. (U.S.), EXTEDO GmbH (U.S.), Online Business Applications, Inc. (U.S.), Oracle Corporation (U.S.), Sarjen Systems Pvt. Ltd (India), Sparta Systems, Inc. (U.S.), and United BioSource Corporation (U.S.) are some of the key players in the global pharmacovigilance and drug safety software market.

About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. 

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Tel: 1-888-600-6441

Parkinson's Disease Treatment Market Worth 5.69 Billion USD by 2022

Parkinson’s disease therapeutic drugs act upon the central nervous system to control or reduce the symptoms of Parkinson’s disease. The global Parkinson’s disease treatment market is expected to reach USD 5.69 billion by 2022 from USD 4.24 billion in 2017, at a CAGR of 6.1%.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=47265247

Globally, the Parkinson’s disease treatment market is witnessing a moderate growth due to factors such as increasing prevalence of Parkinson’s disease; rising geriatric population; and support for research on Parkinson’s disease. 

Over the last few decades, key players operating in this market are focusing on offering new and innovative products. Based on drug class, the Parkinson’s disease therapeutic drugs market is segmented into carbidopa/levodopa dopamine receptor agonists, MAO-inhibitors, COMT-inhibitors, anticholinergics and other drugs. The carbidopa/levodopa segment is expected to register the highest CAGR during the forecast period. This is due to carbidopa/levodopa drugs are more potent and widely used in the treatment of Parkinson’s disease in comparison to other therapeutic drugs.

By distribution channel, the market is segmented into hospital pharmacies, retailer pharmacies, and online pharmacies. The online pharmacies segment is expected to register the highest growth rate during the forecast period. Advancements such as 24/7 availability, home delivery, and discount on medicines are driving factors for online pharmacies segment.

Talk To Our Research Analysts: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=47265247

On the basis of patient care setting, the market is categorized into hospitals and clinics. The hospitals segment is estimated to grow at the fastest rate during the forecast period. The growth of this segment can be attributed to the availability of diagnostics laboratories in the hospital and the presence skilled neurologists.

The Parkinson’s disease treatment market is classified based on regions into North America, Europe, Asia, and the Rest of the World (RoW). Asia is expected to grow at the highest CAGR during the forecast period. Presence key market players and rising aging population are the major factors driving the Parkinson’s disease treatment market in this region. 

HIP Replacement Market Forecast to 2020

The report "HIP Replacement Market by Product (Primary HIP Replacement (Cemented, Cementless), Partial HIP Replacement, Revision HIP Replacement, HIP Resurfacing), Geography (Americas, EU-5, Japan, BRIC, South-East Asia, MEA) - Forecast to 2020", The global hip reconstruction devices market was valued at USD 4.8 Billion in 2014, and is estimated to reach USD 5.9 Billion by 2020, at a CAGR of 3.0% from 2015 to 2020.

Browse 105 market data tables and 114 figures spread through 228 pages and in-depth TOC on "HIP Replacement Market”
http://www.marketsandmarkets.com/Market-Reports/hip-reconstruction-devices-market-76831539.html
Early buyers will receive 10% customization on reports.

The Global Hip Reconstruction Devices market is expected to witness substantial growth due to increasing number of arthritis patients, favorable reimbursement, and technological advancements

The global hip reconstruction devices market growth is attributed to the rise in the number of patients suffering from arthritis, technological advancements, and favorable reimbursement. Despite this, the pricing pressure, waiting list and risk of complications after implantation are some of the major hindering factors.

The government initiative of allocating new funds and development of new policies have reduced the waiting time for hip reconstructions, and increased the number of operations. However, it is difficult to achieve 90% threshold of patients that receive care within the regulated time.

Get PDF Brochure Here :
http://www.marketsandmarkets.com/pdfdownload.asp?id=76831539

The technological advancements in hip reconstruction market, such as newly developed prostheses with improved strength and reliability of joints are reducing the need and cost of revision surgery. The minimally invasive techniques for hip reconstruction surgery will improve the precision and accuracy of surgeons, thus reducing the time of surgery. The emergence of these techniques and other improved surgical tools for the treatment of arthritis is expected to address the rising demand for surgery during the forecast period.

In 2014, the global hip reconstruction devices market was dominated by North America. This market is segmented and forecast on the basis of product, and geography. The product comprises of primary hip reconstruction devices, partial hip reconstruction devices, revision hip reconstruction devices and hip resurfacing devices. The primary hip reconstruction devices are subsegmented into cementless and cemented reconstruction device. The market is further segmented and forecast on the basis of major geographies such as North America, Europe, and Asia-Pacific. These major geographies are further sub-segmented into major countries.

The market in North America is growing due to rising pool of arthritis, and favorable reimbursement. The European market is growing due to the technological advancements and is dominated majorly by Zimmer Inc. (U.S.) and Depuy Synthes (U.S.). The Asian market is growing due to growing health awareness among masses, along with increase in the spending capacity of the Indian population. Also, increasing number of population suffering from musculoskeletal disorders (MSD), government initiatives, and rising awareness towards hip reconstruction are propelling the market growth.

Get Sample Report Here :
http://www.marketsandmarkets.com/requestsample.asp?id=76831539

This report also includes the market share, approach for arriving at the market size, new technology developments, product matrix, life cycle analysis, Porter’s five forces analysis and price analysis by product. In this report, market metrics are also included such as drivers, restraints and upcoming opportunities in the market. In addition, it presents a competitive landscape and company profiles of key players in the market including major companies which provide hip reconstruction devices as a product.

The research study is aimed at identifying emerging trends and opportunities in the global hip reconstruction devices market along with detailed classifications, in terms of revenue. It provides comprehensive competitive landscape and identifies the key players with respect to market size and market share. The research study also includes a detailed segmentation of the global hip reconstruction devices market, on the basis of product, and region.

About MarketsandMarkets
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Disposable Medical Device Sensors Market Worth 5,936 Million USD by 2020

Factors Of Disposable Medical Device Sensors Market  Growth :

Growing prevalence of diabetes and other infectious diseases across the globe, government support for research and development activities in medical sensors, various benefits such as faster analysis, low costs, ease of use, and rising needs to curtail escalating healthcare costs.

The Disposable Medical Device Sensors   market is poised to reach USD 5,936 Million by 2020, growing at a CAGR of 10.3% during the forecast period of 2015 to 2020.

Get PDF Brochure Here :http://bit.ly/2yHXtB3

Key Players:

Some of the major players in this market include Medtronic plc. (Ireland), GE Healthcare (U.K.), Philips N.V. (Netherlands), Smiths Medical (U.K.), TE Connectivity (Switzerland), Freescale Semiconductors, Inc. (U.S.), Omnivision Technologies, Inc. (U.S.), STMicroelectronics (Switzerland), Analog Devices, Inc. (U.S.), and Honeywell International, Inc. (U.S.).

Market Geography :            

North America accounted for the largest share of the market in 2014, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The Asia-Pacific region represents the fastest-growing market for disposable medical device sensors, primarily due to the increasing healthcare expenditure, rising medical tourism, increasing awareness among people for self-health management, and growth in the overall healthcare industry. In addition, increasing investments in the healthcare industry by key market players, rising demand for advanced healthcare technologies, and expansion of private sector hospitals to rural areas in countries such as China, Taiwan, and India are driving the growth of this region.

About Report:

The Disposable Medical Device Sensors   market is segmented into patient monitoring devices, diagnostic testing devices, imaging devices, and therapeutic devices. The diagnostic testing devices segment is further divided into HIV test kits, pregnancy test kits, drug and alcohol test kits, and blood glucose test strips.

The therapeutic devices segment is further divided into insulin pump sensors, dialysis device sensors, cardiac therapy devices, and cardiac catheter sensors. The patient monitoring devices segment is categorized into continuous blood pressure monitors, pulse oximeters, cardiac monitors, continuous glucose monitoring devices, implantable loop recorders, smart pills, and others. The imaging devices segment is divided into capsule endoscopes and disposable endoscopes.

To Know More : http://bit.ly/2yJ6I3V

Growing Geriatric Population Driving Home Health Care Market For Patient Best Experience And Its Outcomes

The Major Factors Driving The Growth

 Asian Home Health Care Market  include the rapidly increasing aging population, increasing incidences of chronic diseases, growing demand for affordable healthcare delivery systems due to increasing healthcare costs, technological advancements, and government
The Asian Home Health Care Market  is expected to reach USD 62.32 Billion by 2020 from USD 39.07 Billion in 2015, at a CAGR of 9.8% from 2015 to 2020.

Get PDF Brochure Here: http://bit.ly/2ukMQBN

 Key Players :

Asian Home Health Care Market  include Philips Healthcare (Netherlands), Linde Group (Germany), Abbott Laboratories (U.S.), Johnson & Johnson (U.S.), A&D Company Limited (Japan), Fresenius SE & Co. KGaA (Germany), Omron Corporation (Japan), Roche Holdings AG (Switzerland), Portea Medical Pvt. Ltd. (India), Teijin Limited (Japan), and GE Healthcare (U.K.).

About Report :

The Asian home health care market is segmented on the basis of products, services, telehealth, and countries. The telehealth market is projected to grow at the highest CAGR during the forecast period. Growth in Asian home health care market can primarily be attributed to the shift of healthcare delivery from traditional clinical settings to home care, technological advancements, and increasing adoption of telecommunication technologies.

Based on products, the market is further segmented into testing, screening, and monitoring products; therapeutic products; and mobility care products. The testing, screening, and monitoring products segment is estimated to account for the largest market share in 2015.

To Know More : http://bit.ly/2vIMY1u

Pyrogen Testing Market - Global Forecasts to 2021

The report "Pyrogen Testing Market by Product (Instruments, Services, Kits and Reagents), Application (Pharmaceutical & Biotechnology, Medical Devices, Other), & by Test (In Vitro, LAL, Gel Clot, Turbidimetric, Chromogenic, Rabbit) - Global Forecasts to 2021"The global Pyrogen Testing market was valued at USD 610.2 Million in 2016. This market is expected to grow at a CAGR of 12.2% to reach USD 1086.3 Million in 2021.

Browse 74 market data Tables and 95 Figures spread through 173 Pages and in-depth TOC on "Pyrogen Testing Market”
http://www.marketsandmarkets.com/Market-Reports/pyrogen-testing-market-255266155.html
Early buyers will receive 10% customization on this report.

Rapidly increasing pharmaceutical and biotechnology industries and increasing number of new biologics products launched will be the two most important growth drivers for this market during the forecast period. For instance, the number of new biologics products launched annually witnessed a strong upward trend between 2003 and 2013.

The number of new products launched in 2013 was 56 as compared to 29 in 2003. The biologics pipeline has increased by 155%, from 355 treatments in 2001 to 907 in 2012. A strong pharmaceutical product pipeline will aid the growth of the pharmaceutical and biotechnology industry, which is an important application of pyrogen testing products

Get The Sample Report For This Report@ 
http://www.marketsandmarkets.com/requestsample.asp?id=255266155

The global pyrogen testing market is segmented on the basis of applications, products, tests, and geographies.
By application, the market is divided into pharmaceuticals and biologicals manufacturing, medical devices manufacturing, and other applications such as water purification, food and beverages, cosmetics, and plastics and glass products. Of these, the pharmaceuticals and biologicals manufacturing segment accounted for the largest share of the global pyrogen testing market in 2016. The large share of this segment can primarily be attributed to the rapid growth in pharmaceutical and biotechnology industries.

The test segments included in this report are in vitro pyrogen test, LAL (Limulus Amebocyte Lysate) test, and Rabbit test. Of these the LAL (Limulus amebocyte lysate) test holds the highest share. The large share of LAL test can primarily be attributed to its advantages such as accuracy, speed, requirement of small amount of the tested sample, more economical, and allows detection of lower level of endotoxins, and flexibility in life science research.  The LAL test is further sub-segmented in to chromogenic tests, turbidimetric tests, and gel clot tests.

Get The PDF Brochure For This Report@ 
http://www.marketsandmarkets.com/pdfdownload.asp?id=255266155

The product segments included in the report are kits and reagents, services, and Instruments. The kits & reagents segment commanded the largest share of global pyrogen testing market. The large share of this segment can mainly be attributed to repeat purchase of kits and reagents as compared to instruments, and increasing adoption of kit-based testing.

The geographic segments included in this report are Asia, Europe, North America, and the Rest of the World (RoW). North America is further segmented into the U.S. and Canada; Europe is further segmented into France, Germany, Italy, Spain, the U.K., and the Rest of Europe (RoE); Asia is further segmented into China, Japan, and India, and the Rest of Asia; and the Rest of the World (RoW) is divided into Africa, Pacific and Oceania, and South America, Central America, and the Caribbean.

Major players in the pyrogen testing market include Associates of Cape Cod, Inc. (U.S.)  Charles River Laboratories International, Inc. (U.S.), Ellab A/S (Denmark), GenScript (U.S.), Hyglos GmbH (Germany), Lonza Group (Switzerland), Merck KGaA (Germany), Thermo Fisher Scientific, Inc. (U.S.), Wako Chemicals USA Inc. (U.S.), and Wuxi PharmaTech (CAYMAN) Inc. (China).

About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. 

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Tel: 1-888-600-6441

Current and Future Trends Of Blood Screening Market

The Key Factor For growth Of  Blood Testing Market :

•             Increasing number of blood donations and blood donors

•             Growing affordability and adoption of nucleic acid test (NAT) for blood screening,

•             Rising awareness regarding the safety of donated blood,

•             Growing demand for donated blood, and increasing prevalence/incidence of infectious

              diseases.

Get PDF Brochure Here: http://bit.ly/2w8Bimx

Based on technology, the Blood Testing Market is segmented into NAT, ELISA, rapid tests, western blot assay, and NGS. The ELISA segment is projected to grow at the highest CAGR during the forecast period. The major factors contributing to the growth of this segment include increasing number of donations, growing prevalence of infectious diseases, and the increasing demand for donated blood around the world.

Based on product and service, the Blood Testing Market is segmented into reagents & kits, instruments, and software & services. The reagents & kits segment is further subsegmented into NAT, ELISA, and other reagents and kits. The ELISA reagents and kits segment is expected to register the highest growth during the forecast period. This growth can be attributed to the high consumption and repeated use of reagents and kits in blood screening procedures.

Based on region, the Blood Testing Market is segmented into North America, Europe, Asia, and Rest of the World (RoW). The Asian market is expected to grow at the highest CAGR during the forecast period due to increasing prevalence and incidence of infectious diseases, high demand for donated blood, and increased awareness among people regarding the safety of donated blood.

To Know More : http://bit.ly/2vrmNMH

LAL Assays Widely Used for Pyrogen Testing | Asian Market Poised for Rapid Growth

Pyrogen Testing Market, By Product (Instruments, Services, Kits & Reagents), By Test (In Vitro, LAL, Rabbit Test), By Application (Pharmaceutical & Biotechnology Companies, Medical Devices, Other Applications) – Global Forecast to 2019

Pyrogen testing is mandatory for all drugs and medical devices intended for medical or veterinary use. Pyrogen testing is carried out at all levels of pharmaceutical and biopharmaceutical manufacturing process to minimize the risk of product contamination. Growth in pharmaceutical and biotechnology industries will drive the growth of the pyrogen testing market. The growth of this industry will also be aided by increase in number of new drug launches, strong trend of R&D in life science, and increasing government support for the pharmaceutical and biotechnology industries.

Download PDF Brochure :http://www.marketsandmarkets.com/pdfdownload.asp?id=255266155

The test segments included in this report are in vitro pyrogen test, LAL test, and rabbit test. The LAL test will be major revenue pockets for the pyrogen testing market in the forecast period (2014-2019). The LAL test is the most widely used test method in the pyrogen testing market, and is also expected to grow at the highest rate amongst all test segments in this market. In fact, the estimated market size of LAL test in 2019 is expected to be larger than the combined market size of the other two test segments in that year. The Limulus Amebocyte Lysate (LAL) test is gold standard method for detection of bacterial toxins or pyrogens.

The LAL test method is an alternative method for rabbit pyrogen test to detect pyrogens in sterile parenteral drugs. The ease of use of LAL test and its cost advantages over other test like rabbit test makes it the most widely used test in this market. Another important advantage of LAL test over the rabbit test is that LAL test is in accordance with the requirements of the European Pharmacopoeia Commission (Ph. Eur.) for the replacement of the animal-based tests. The Ph. Eur. is in favor of alternative methods where possible.

North America accounted for the largest share of the global pyrogen testing market in 2014. Asia is expected to grow at the highest CAGR in the forecast period for this report (2014–2019), and represents an important revenue pocket for the pyrogen testing market. Asia is expected to witness a steady year-on-year growth, owing to the trend of outsourcing drug discovery research activities to countries in this geography. 

Moreover, an increase in government support for pharmaceutical and biotechnology industries in this region will further fuel the demand for products offered in the pyrogen testing market. For instance, beginning in 2014, the Indian government plans to invest up to $5 billion a year for the next five years, to boost the biotechnology sector in the country and make it a $100 billion industry by 2025. Similarly, the Chinese government is also taking various initiatives to promote life sciences research, and plans to invest more than $300 billion in biotechnology from 2012 to 2017.

To Know More : http://www.marketsandmarkets.com/requestsample.asp?id=255266155

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Tel: 1-888-600-6441

Surgical Staplers Market | Driven By Increasing Number of Surgical Procedures

Major Factor For The Growth Of Market :
A number of factors such as increasing number of surgical procedures across the globe, growing preference for minimally invasive surgeries, technological advancements, and increasing preference for surgical staplers over sutures are expected to drive the growth of the market. On the other hand, high cost of devices and availability of alternative wound care techniques may hinder the growth of the market in the coming years.

The global Surgical Staplers Market is expected to reach USD 4.78 Billion by 2022 from USD 3.38 Billion in 2017, at a CAGR of 7.2%.

Get PDF Brochure Here : http://bit.ly/2xqTFX7

Key players :
The Surgical Staplers Market  is duopolistic in nature with two major players Ethicon Inc. (U.S.) and Medtronic plc (Ireland). CONMED Corporation (U.S.), Smith & Nephew (U.K.), Purple Surgical Inc. (U.K.), Intuitive Surgical Inc. (U.S.), Welfare Medical Ltd. (U.K.), Reach surgical Inc. (China), Meril Life Science Pvt. Ltd. (India), Grena Ltd. (U.K.), B. Braun Melsungen AG (Germany), Dextera Surgical Inc. (U.S.), Frankenman International (China), and Becton, Dickinson and Company (U.S.) are some of the other players operating in the global Surgical Staplers Market.

About Report :
Based on product, the market is segmented into Manual Surgical Stapler and Powered Surgical Stapler. The manual surgical stapler segment is expected to account for the largest share of the surgical stapler market in 2017. Manual Surgical Staplers are faster, more economical, and cause fewer infections than stitches. It also causes low tissue reactivity, which helps in preventing SSIs as compared to conventional methods available for wound closure such as sutures.

Based on the application, the market is segmented into abdominal & pelvic surgery, general surgery, cardiac and thoracic surgery, orthopedic surgery, and other surgical applications. In 2017, abdominal & pelvic surgery is expected to account for the largest share of the market. The large share of this segment can primarily be attributed to the increasing prevalence of obesity, growing health consciousness across the globe, increasing purchasing power, and growth in the number of bariatric or weight loss surgeries across the globe.

By end user, the market is segmented into hospitals and ambulatory surgical centers (ASCs) & clinics. In 2017, the hospitals segment is expected to account for the largest share of the market. Rapidly increasing patient volume and the subsequent increase in the number of complex surgeries, easy accessibility to multiple specialty treatments in a single facility, and favorable reimbursements are the major factors driving the growth of this end-user segment.

 To Know More : Click Here

Growth In The Number of Surgeries Among Animals Are Responsible For Driving Veterinary Surgical Instruments

The increasing demand for veterinary surgical instruments is driven by the rising companion animal population coupled with the growing demand for pet insurance, the rising animal health awareness levels along with the increasing animal healthcare expenditure. In addition, the growth in the number of veterinary practitioners and the growth in the number of soft tissue injuries and trauma surgeries among pets are responsible for driving the overall growth of this market.

The global veterinary surgical instruments market is estimated to reach USD 1,029.0 Million by 2021 from USD 748.4 Million in 2016, grow at a CAGR of 6.6% during the forecast period.

Download PDF Brochure Here: http://bit.ly/2f7q6CL

Key Players:

The market players, namely, B. Braun Vet Care GmbH (Germany), Medtronic Plc. (Ireland), Ethicon Inc. (U.S.), and JORGEN KRUSSE A/S (Denmark) held the major share of the Veterinary Surgical Instruments Market  and will continue to dominate the market between 2016 and 2021.

Market Geography:

The global Veterinary Surgical Instruments Market  is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2015, North America commanded a major share of the market. However, Asia-Pacific is expected to witness the highest growth rate during the forecast period.

About Report :

Based on product type, the market is segmented into sutures, staplers and accessories, handheld devices, electro-surgery instruments, and others. The handheld devices are further segmented into forceps, scalpels, surgical scissors, hooks & retractors, and trocars & cannulas. 

Based on animal type, the market is segmented into small animals and large animals. The small animals segment is further segmented into canines, felines, and other small animals, while the large animals segment is further segmented into equines and other large animals.

To Know More : http://bit.ly/2wYwa7r

Growth Of Dialysis Market In Emerging Nations ..!!

The rising prevalence of end-stage renal disease (ESRD), diabetes, and hypertension is stimulating the demand for dialysis treatment in the emerging nations. Furthermore, low preference of patients for kidney transplantation, technological advancements, and substantial government healthcare expenditure on the treatment of ESRD are adding to the growth prospects of dialysis products and services market in the emerging nations.

Get PDF Brochure Here : http://bit.ly/2wg2Vgs

Key players :

The major players in the Dialysis market in emerging nationsinclude Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (U.S.), B. Braun Melsungen AG (Germany), Nipro Corporation (Japan), and Nikkiso Co. Ltd. (Japan). On the basis of region, the Dialysis market in emerging nations is segmented into India, Asia (excluding India), and the MENA region.

 Market Geography:

The market in Asia is expected to grow at a higher rate during the forecast period (2015-2020). This high growth is predominantly driven by the growing number of Dialysis centers, low preference for kidney transplantation, rising awareness about renal diseases, development of low-cost products, and increasing focus of Dialysis firms on the Asian market. 

About Report :

The Dialysis market in emerging nations is categorized into two broad segments, namely, Hemodialysis and peritoneal Dialysis. The Hemodialysis market is segmented into products and services. Hemodialysis products include Hemodialysis machines and Hemodialysis consumables/supplies, whereas Hemodialysis services are classified into in-center services and home services. The peritoneal Dialysis market, segmented into products and services, includes peritoneal Dialysis machines, concentrates/dialysates, catheters, transfer sets, and other consumables such as tubing sets, drain bags, disconnect caps, bag connections, catheter stabilizing devices, and ports.

To Know More : http://bit.ly/2uOr11J

Global Fertility Testing Devices Market Is Poised To Grow At A CAGR Of 7.5% During The Forecast Period To Reach USD 216.8 Million By 2020

Major Factor For The Growth of Fertility Testing Devices Market :
The emergence of advanced and easy-to-use ovulation monitors with high accuracy, rising median age of first-time pregnancies in women, and increasing awareness about fertility testing are driving the growth of the market. In addition, factors such as declining fertility rate among women across the globe and easy availability of ovulation monitors on e-commerce websites are further stimulating the growth of the market.

Download PDF  Brochure: http://bit.ly/2hZdK0c

The global Fertility Testing Devices  market is poised to grow at a CAGR of 7.5% during the forecast period and expected to reach a value of USD 216.8 Million by 2020.

Market Geography :

Fertility Testing Devices  market is divided into North America (comprising the U.S. and Canada), Europe (comprising Germany, U.K., France, and the Rest of Europe), Asia-Pacific, and the Rest of the World.

Key Players :

Fertility Testing Devices  market include SPD Swiss Precision Diagnostics GmbH (Switzerland), Church & Dwight Co., Inc. (U.S.), Prestige Brands Holdings, Inc. (U.S.), Fairhaven Health, LLC (U.S.), HiLin Life Products, Inc. (U.S.), Fertility Focus Limited (U.K.), and Geratherm Medical AG (Germany).

About Report :

The global Fertility Testing Devices  market is broadly categorized into two segments, namely, ovulation prediction kits and fertility monitors. The ovulation prediction kits segment accounts for the larger share of the global market, while the fertility monitors segment is expected to grow at the higher CAGR in the forecast period.

The high growth of this segment is driven by the high accuracy of fertility monitors, especially in women suffering from PCOS, and increase in the number of product launches of advanced fertility monitors. The fertility monitors segment includes saliva-based monitors, urine-based monitors, and others.

To Know More: Click Here

Current scenario and the future growth prospects of the “Cardiovascular Ultrasound System”

Major Factor Driving The Market Growth :

Increasing incidence of cardiovascular diseases, technological advancements, and advantages of echocardiography over invasive cardiac diagnostic procedures are the major drivers for the Cardiovascular Ultrasound System Market . However, insufficient reimbursement scenario and economic impact of adopting new technologies are restraining the growth of the market.

Download PDF Brochure: http://bit.ly/2eV9fiK

The Cardiovascular Ultrasound System Market is projected to reach USD 1.66 Billion by 2021 from USD 1.27 Billion in 2016, growing at a CAGR of 5.4% during the forecast period (2016–2021)

Key players :

Key players in the Cardiovascular Ultrasound System Market  include GE Healthcare (U.S.), Philips healthcare (The Netherlands), Siemens Healthcare (Germany), Hitachi Medical Corporation (Japan), and Toshiba Medical Systems Corporation (Japan).

About Report :

The Cardiovascular Ultrasound System Market  is broadly segmented into test type, technology, device display, end user, and region. Based on test type, the market is categorized into transthoracic echocardiogram, stress echocardiogram, transesophageal echocardiogram, and fetal & intracardiac echocardiogram. The stress echocardiogram segment is expected to account for the largest share of the market in 2016. This is due to the major advantage of the stress echocardiogram that it can provide data of the cardiac muscles and valves before and after the stress of the heart muscle.

On the basis of technology, the Cardiovascular Ultrasound System Market  is segmented into 2D, 3D & 4D, and Doppler imaging. The 2D technology is estimated to account for the largest share of the market in 2016, whereas the 3D & 4D technology segment is estimated to grow at the highest CAGR during the forecast period.

To Know More : http://bit.ly/2wZOVW1

FDA and Ce Mark Approvals Driving the Adoption of Surgical Sealants and Adhesives

Major Factor Which Are Driving The Growth Of Surgical Sealants and Adhesives Market :

Increasing incidence of chronic diseases along with the rapid growth in the geriatric population, increasing need manage blood loss in patients, and growing number of surgical procedures performed are the major factors driving the growth of the surgical sealants and adhesives market

                                                           

Get PDF Brochure Here : http://bit.ly/2hMM8eA

On the basis of product, the market is segmented into natural/biological sealants and adhesives and synthetic & semi-synthetic sealants and adhesives. The natural/biological sealants and adhesives segment is further categorized into type and origin.

On the basis of type, the natural/biological sealants segment have been divided into polypeptide/protein-based and polysaccharide-based sealants and adhesives. The polypeptide/protein-based sealants segment is further categorized into fibrin, gelatin, collagen, and albumin-based adhesives, while the polysaccharide-based sealants segment comprise of chitosan-based and other polysaccharide-based adhesives.

 On the basis of origin, the natural/biological sealants and adhesives segment is categorized into human blood-based and animal-based. The synthetic and semi-synthetic sealants and adhesives segment is divided into cyanoacrylates, polyethylene glycol hydrogels, urethane-based adhesives, and other synthetic adhesives.

On the basis of application, the global surgical sealants and adhesives market is segmented into CNS, general, cardiovascular, orthopedic, cosmetic, urological, pulmonary, ophthalmic surgeries, and other applications.

To Know More : http://bit.ly/2fuaGZi